- Filed
- Feb 13, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · Feb 11, 2026 | 298.21M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2025 | 33.74M sh |
| Shares Diluted | Q1 2026 · Dec 31, 2024 | 23.58M sh |
| Operating Cash Flow | Q1 2026 · Dec 31, 2025 | −$2.92M |
| Operating Cash Flow | Q1 2026 · Dec 31, 2024 | $1.46M |
| Cash And Equivalents | Q1 2026 · Dec 31, 2025 | $13.06M |
| Cash And Equivalents | Q1 2026 · Sep 30, 2025 | $1.31M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $3.52M |
| Stockholders Equity | Q1 2026 · Sep 30, 2025 | $407K |
| Stockholders Equity restated | Q1 2026 · Dec 31, 2024 | −$63.67M |
| Stockholders Equity | Q1 2026 · Sep 30, 2024 | −$55.12M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $23.53M |
| Current Liabilities | Q1 2026 · Sep 30, 2025 | $3.54M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $23.53M |
| Total Liabilities | Q1 2026 · Sep 30, 2025 | $8M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $18.84M |
| Current Assets | Q1 2026 · Sep 30, 2025 | $8.13M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $27.05M |
| Total Assets | Q1 2026 · Sep 30, 2025 | $8.4M |
| Eps Diluted | Q1 2026 · Dec 31, 2025 | −$0.26 |
| Eps Diluted | Q1 2026 · Dec 31, 2024 | −$0.17 |
| Eps Basic | Q1 2026 · Dec 31, 2025 | −$0.26 |
| Eps Basic | Q1 2026 · Dec 31, 2024 | −$0.17 |
| Sga Expense | Q1 2026 · Dec 31, 2025 | $4.84M |
| Net Income | Q1 2026 · Dec 31, 2025 | −$8.61M |
| Net Income | Q1 2026 · Dec 31, 2024 | −$3.98M |
| Operating Income | Q1 2026 · Dec 31, 2025 | −$3.79M |
| Gross Profit | Q1 2026 · Dec 31, 2025 | $1.05M |
| Revenue | Q1 2026 · Dec 31, 2025 | $2.81M |